Dr. Reddy's Laboratories Limited has received an order dated 23rd Sep 2024, from COFEPRIS (Comisión Federal para la Protección Contra Riesgos Sanitarios) health department of Mexico.
The drug regulatory body of Mexico (Comisión Federal para la Protección contra Riesgos Sanitarios or Cofepris) has imposed a penalty of MXN 651, 420 (~INR 28 Lakh) on the Company for deviation from prescribed guidelines for filing intimation of import of a reference standard for one of our APIs. The intimation was filed by the Company upon arrival of the reference standard in Mexico as opposed to three days in advance as required.
Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 6693.65 as compared to the previous close of Rs. 6650.90. The total number of shares traded during the day was 9811 in over 3223 trades.
The stock hit an intraday high of Rs. 6705.00 and intraday low of 6596.00. The net turnover during the day was Rs. 65254257.00.